Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

Announcement on Completion of Administration of the First Subject in Phase II Clinical Trial of GZR102 Injection

· Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Completion of Administration of the First Subject in Phase II Clinical Trial of GZR102 Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis